Xenetic Biosciences


Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.

Industries

Employees

11-50

Links


Org chart

James F. Parslow
Chief Financial Officer
Jim Parslow, CPA, MBA
Chief Financial Officer

Board & advisors

Adam Logal
Chairman, Board of Directors
Grigory G. Borisenko
Non-Executive Director
James Eric Callaway
Non-Executive Director
Firdaus Jal Dastoor
Non-Executive Director
Roger Kornberg
Non-Executive Director
Alexey Vinogradov
Non-Executive Director
Matthew Frigault
Scientific Advisor
Guenther Koehne
Scientific Advisor
Maksim Mamonkin
Scientific Advisor
Allan Tsung
Scientific Advisor
Jonathan Spicer
Scientific Advisor


Offices